References
- National Center for Health Statistics. Asthma Prevalence, Health Care Use and Mortality, 2002. Centers for Disease Control and Prevention, Hyattsville, MD 2002, http://www.cdc.gov/nchs/products/pubs/ pubd/hestats/asthma/asthma.htm Available at, Accessed April 21, 2005
- National Heart, Lung, and Blood Institute. U.S. Department of Health & Human Services, Asthma. Diseases and Conditions Index. 2003, http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma/ Asthma_All.html Available at, Accessed April 11, 2005
- U.S. Environmental Protection Agency. Asthma and Indoor Enviroments. Washington, DC 2005, http://www.epa.gov/iaq/asthma/ about.html Available at, Accessed April 11, 2005
- Centers f or. Disease Control and Prevention. Surveillance for Asthma-United States, 1980–1999. MMWR Surveillance Summaries. Atlanta, GA 2002, http://www.cdc.gov/ mmwr/preview/mmwrhtml/ss5101a1.htm. [March 13, 2002; 51 (no. SS-1)]. Available at, Accessed April 21, 2005
- National Institute of Allergy and Infectious Diseases. (NIH), National Institute of Health, Asthma 2005, http://www2.niaid.nih.gov/ Newsroom/FocusOn/Asthma01/basics.htm#what Available at, Accessed April 11, 2005
- Hospenthal M A, Peters J I. Long-acting beta(2)-agonists in the management of asthma exacerbations. Curr Opin Pulm Med 2005; 11: 69–73
- Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001; 5: 1–149
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. National Heart, Lung and Blood Institute (NHLBI), Bethesda, MD 2005; 184, [1372 references]
- Sin D D, Man J, Sharpe H, et al. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. Jama 2004; 292: 367–376
- Ernst E. Complementary therapies for asthma: what patients use. J Asthma 1998; 35: 667–671
- Kessler R C, Davis R B, Foster D F, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001; 135: 262–268
- Perlman A, Serbin J S. Complementary and Alternative Medicine: Does it have a Role in Treating Adthma?. Woman's Health in Primary Care 2001; 4: 284–288
- Eisenberg D M, Davis R B, Ettner S L, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. Jama 1998; 280: 1569–1575
- Furnham A, Kirkcaldy B. The health beliefs and behaviours of orthodox and complementary medicine clients. Br J Clin Psychol 1996; 35(Pt 1)49–61
- Vincent C, Furnham A. Why do patients turn to complementary medicine?. An empirical study. Br J Clin Psychol 1996; 35(Pt 1)37–48
- Astin J A. Why patients use alternative medicine: results of a national study. Jama 1998; 279: 1548–1553
- Winslow L C, Kroll D J. Herbs as medicines. Arch Intern Med 1998; 158: 2192–2199
- Steurer-Stey C, Russi E W, Steurer J. Complementary and alternative medicine in asthma: do they work?. Swiss Med Wkly 2002; 132: 338–344
- Ng T P, Wong M L, Hong C Y, et al. The use of complementary and alternative medicine by asthma patients. Qjm 2003; 96: 747–754
- Huntley A, Ernst E. Herbal medicines for asthma: a systematic review. Thorax 2000; 55: 925–929
- Deeks J J, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7: iii–x; 1–173
- MacLehose R R, Reeves B C, Harvey I M, et al. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess 2000; 4: 1–154
- National Center for Complementary and Alternative Medicine. Get The Facts: Herbal Supplements: Consider Safety, too. National Institutes of Health, Bethesda, Maryland Sept., 2004, http://nccam.nih.gov/ health/supplement-safety/ Available at, Accessed May 11, 2005,
- Egbert Fosten Publishing. Annotated Bibliography of Indian Medicine. GroningenNetherlands April, 2006, http://www.ub.rug.nl/indianmedicine/index.htm. Available at, Accessed May 5, 2005
- Jadad A R, Moore R A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17: 1–12
- Singh B B, Mishra L C, Gandhi S, et al. Ayurvedic and Collateral Herbal Treatment of Liver Diseases: A Systematic Review of Randomized Control Trials and Quasi-Experimental Designs. NAMA, Long Beach 2004
- Singh B B, Vinjamury S P, Singh V J. Clinical Research Design: Limited Systematic Review of Five Diagnostic Categories. Scientific Basis for Ayurvedic Therapies, L C Mishra. CRC Press, New York 2004; 31–41
- Shivpuri D N, Menon M P, Parkash D. Preliminary studies in Tylophora indica in the treatment of asthma and allergic rhinitis. J Assoc Physicians India 1968; 16: 9–15
- Shivpuri D N, Agarwal M K. Effect of Tylophora indica on bronchial tolerance to inhalation challenges with specific allergens. Ann Allergy 1973; 31: 87–94
- Gore K V, Rao A K, Guruswamy M N. Physiological studies with Tylophora asthmatica in bronchial asthma. Indian J Med Res 1980; 71: 144–148
- Gupta S, George P, Gupta V, et al. Tylophora indica in bronchial asthma–a double blind study. Indian J Med Res 1979; 69: 981–989
- Shivpuri D N, Menon M P, Prakash D. A crossover double-blind study on Tylophora indica in the treatment of asthma and allergic rhinitis. J Allergy 1969; 43: 145–150
- Shivpuri D N, Singhal S C, Parkash D. Treatment of asthma with an alcoholic extract of tylophora indica: a cross-over, double-blind study. Ann Allergy 1972; 30: 407–412
- Mathew K K, Shivpuri D N. Treatment of asthma with alkaloids of Tylophora indica: a double blind study. Aspects Allergy Appl Immunol 1974; 7: 166–179
- Thiruvengadam K V, Haranath K, Sudarsan S, et al. Tylophora indica in bronchial asthma: a controlled comparison with a standard anti-asthmatic drug. J Indian Med Assoc 1978; 71: 172–176
- Doshi V B, Shetye V M, Mahashur A A, et al. Picrorrhiza kurroa in bronchial asthma. J Postgrad Med 1983; 29: 89–95
- Bikshapathi T, Tripathi S N, Pandey B L. Clinical evaluation of picrorhiza kurroa royle. ex benth. (kutki) in the management of chronic obstructive airway disease. J Res Ayurveda Siddha 1996; 17: 126–148
- Govindan S, Viswanathan S, Vijayasekaran V, et al. A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. J Ethnopharmacol 1999; 66: 205–210
- Bector N P, Puri A S. Solanum xanthocarpum (Kantakari) in chronic bronchitis, bronchial asthma and non-specific unproductive cough. (An experimental and clinical co-relation). J Assoc Physicians India 1971; 19: 741–744
- Govindan S, Viswanathan S, Vijayasekaran V, et al. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytother Res 2004; 18: 805–809
- Gupta P P, Dubey S D, Mishra J K, et al. A comparative study on brihati and kantakari in shvasa and kasa. J Res Ayurveda Siddha 1999; 20: 191–194
- Jain J P. A clinical trial of kantakari (Solanum xanthocarpum) in cases of tamak swasa (some respiratory diseases). J Res Ayurveda Siddha 1980; 1: 447–460
- Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 1998; 3: 511–514
- Swamy G K, Bhattathiri P PN, Rao P V, et al. Clinical evaluation of sirisa twak kvatha in the management of tamaka shwasa (bronchial asthma). J Res Ayurveda Siddha 1997; 18: 21–27
- Trivedi V P, Nesamany S, Sharma V K. A clinical study of the anti-tussive and anti-asthmatic effects of vibhitakyadi churna (Terminalia belerica Roxb.) in the cases of kasa-swasa. J Res Ayurveda Siddha 1982; 3: 1–8
- Suresh A, Anandan T, Sivanandam G, et al. A pilot study of naayuruvi kuzhi thailam in eraippu noi (bronchial asthma). J Res Ayurveda Siddha 1985; 6: 171–176
- Sekhar A V, Gandhi D N, Rao N M, et al. An experimental and clinical evaluation of anti-asthmatic potentialities of Devadaru compound (DC). Indian J Physiol Pharmacol 2003; 47: 101–107
- Sharma G D, Upadhyay B N, Tripathi S N. A clinical trial of Euphorbia prostrata W.Ait. and Thymifolia E. Linn. in the treatment of bronchial asthma (tamaka shvasa). J Res Ayurveda Siddha 1982; 3: 109–118
- Kumar S S, Shanmugasundaram K R. Amrita Bindu–an antioxidant inducer therapy in asthma children. J Ethnopharmacol 2004; 90: 105–114
- Shankar A, Parsai M R, Naqvi S MA, et al. A clinical trial of bharangi in cases of tama ka swasa (bronchial asthma). J Res Ayurveda Siddha 1980; 1: 470–478
- Jain J P, Naqvi S MA, Sharma K D. A clinical trial of volatile oil of Curcuma longa Linn. (haridra) in cases of bronchial asthma (tamaka swasa). J Res Ayurveda Siddha 1990; 11: 20–30
- Iyengar M A, Jambaiah K M, Kamath M S, et al. Studies on an antiasthma kada: a proprietary herbal combination part I clinical study. Indian Drugs 1994; 31: 183–186
- Schapowal A. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. Bmj 2002; 324: 144–146
- Lee D K, Carstairs I J, Haggart K, et al. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy 2003; 33: 882–886
- Lee D K, Haggart K, Robb F M, et al. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy 2004; 34: 110–114
- Danesch U C. Petasites hybridus (Butterbur root) extract in the treatment of asthma–an open trial. Altern Med Rev 2004; 9: 54–62
- Juergens U R, Stober M, Schmidt-Schilling L, et al. Antiinflammatory effects of euclyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo. Eur J Med Res 1998; 3: 407–412
- Juergens U R, Dethlefsen U, Steinkamp G, et al. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med 2003; 97: 250–256
- Tashkin D P, Shapiro B J, Frank I M. Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis 1974; 109: 420–428
- Vachon L, Mikus P, Morrissey W, . Bronchial effect of marihuana smoke in asthma. The pharmacology of marihuana, M C Braude, S Szara, et al. Raven Press, New York 1976; 777–784
- Tashkin D P, Shapiro B J, Lee Y E, et al. Effects of smoked marijuana in experimentally induced asthma. Am Rev Respir Dis 1975; 112: 377–386
- Tashkin D P, Shapiro B J, Frank I M. Acute effects of marihuana on airway dynamics in spontaneous and experimentally induced bronchial asthma. The pharmacology of marihuana, M C Braude, S Szara. Raven Press, New York 1976; 785–801
- Ebden P, Bevan C, Banks J, et al. A study of evening primrose seed oil in atopic asthma. Prostaglandins Leukot Essent Fatty Acids 1989; 35: 69–72
- Kalus U, Pruss A, Bystron J, et al. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res 2003; 17: 1209–1214
- Haggag E G, Abou-Moustafa M A, Boucher W, et al. The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma. J Herb Pharmacother 2003; 3: 41–54
- Blanc P D, Kuschner W G, Katz P P, et al. Use of herbal products, coffee or black tea, and over-the-counter medications as self-treatments among adults with asthma. J Allergy Clin Immunol 1997; 100: 789–791
- Reznik M, Ozuah P O, Franco K, et al. Use of complementary therapy by adolescents with asthma. Arch Pediatr Adolesc Med 2002; 156: 1042–1044
- Bielory L, Lupoli K. Herbal interventions in asthma and allergy. J Asthma 1999; 36: 1–65
- Moher D, Pham B, Klassen T P, et al. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol 2000; 53: 964–972
- Pham B, Klassen T P, Lawson M L, et al. Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary. J Clin Epidemiol 2005; 58: 769–776
- Klassen T P, Pham B, Lawson M L, et al. For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine. J Clin Epidemiol 2005; 58: 763–768
- Linde K, Jonas W B, Melchart D, et al. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001; 30: 526–531